Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Nature ; 608(7923): S30-S31, 2022 08.
Artículo en Inglés | MEDLINE | ID: covidwho-2000857
2.
Am J Trop Med Hyg ; 106(1): 17-20, 2021 11 10.
Artículo en Inglés | MEDLINE | ID: covidwho-1703423

RESUMEN

The current COVID-19 pandemic has affected the ability of health systems to provide essential services globally. The Darfur region, located in the western part of Sudan, has been largely devastated by the war that began in 2003 and has been drawing considerable attention from the international community. The war, which erupted as a result of environmental, political, and economic factors, has led to tragic outcomes. Collapsing health-care infrastructures, health workforce shortages, lack of storage facilities for medicines and medical products, and inadequate access to health services are some of the effects of the war. After Sudan received the AstraZeneca COVID-19 vaccine through the COVID-19 Vaccines Global Access facility, significant challenges have been implicated in the delivery, storage, and use of the vaccine in the Darfur region. Lack of vaccine storage and transportation facilities, vaccination hesitancy, inequity in the distribution to health facilities, and shortage of health-care professionals resulting from insecurity and instability have added an extra layer of burden on local authorities and their ability to manage COVID-19 vaccinations in the region adequately. Addressing the impact of COVID-19 requires an effectively managed vaccination program. In the face of current challenges in Darfur, ensuring a fully vaccinated population might remain far-fetched and improbable if meaningful efforts are not put in place by all stakeholders and actors to address some of the challenges identified.


Asunto(s)
Vacunas contra la COVID-19/administración & dosificación , COVID-19/prevención & control , Vacunación , Almacenaje de Medicamentos/métodos , Almacenaje de Medicamentos/normas , Fuerza Laboral en Salud/estadística & datos numéricos , Humanos , Refrigeración/normas , Sudán , Transportes/normas , Vacunación/tendencias , Vacilación a la Vacunación/tendencias
3.
ACS Nano ; 14(7): 7704-7713, 2020 07 28.
Artículo en Inglés | MEDLINE | ID: covidwho-1387152

RESUMEN

We advocate the widespread use of UV-C light as a short-term, easily deployable, and affordable way to limit virus spread in the current SARS-CoV-2 pandemic. Radical social distancing with the associated shutdown of schools, restaurants, sport clubs, workplaces, and traveling has been shown to be effective in reducing virus spread, but its economic and social costs are unsustainable in the medium term. Simple measures like frequent handwashing, facial masks, and other physical barriers are being commonly adopted to prevent virus transmission. However, their efficacy may be limited, particularly in shared indoor spaces, where, in addition to airborne transmission, elements with small surface areas such as elevator buttons, door handles, and handrails are frequently used and can also mediate transmission. We argue that additional measures are necessary to reduce virus transmission when people resume attending schools and jobs that require proximity or some degree of physical contact. Among the available alternatives, UV-C light satisfies the requirements of rapid, widespread, and economically viable deployment. Its implementation is only limited by current production capacities, an increase of which requires swift intervention by industry and authorities.


Asunto(s)
Aire Acondicionado/normas , Infecciones por Coronavirus/transmisión , Transmisión de Enfermedad Infecciosa/prevención & control , Desinfección/métodos , Calefacción/normas , Neumonía Viral/transmisión , Ventilación/normas , Aire Acondicionado/efectos adversos , COVID-19 , Espacios Confinados , Infecciones por Coronavirus/epidemiología , Calefacción/efectos adversos , Humanos , Pandemias , Neumonía Viral/epidemiología , Transportes/normas , Rayos Ultravioleta
4.
New Solut ; 31(1): 20-29, 2021 05.
Artículo en Inglés | MEDLINE | ID: covidwho-1067101

RESUMEN

Home care aides are on the frontlines providing care to vulnerable individuals in their homes during the COVID-19 pandemic yet are often excluded from policies to protect health care workers. The goal of this study was to examine experiences of agency-employed home care aides during the COVID-19 pandemic and to identify ways to mitigate concerns. We used an innovative journaling approach with thirty-seven aides as well as in-depth interviews with fifteen aides and leadership representatives from nine home health agencies in New York and Michigan. Workers described a range of concerns around workplace safety including uncertainty around whether a client had COVID-19, inadequate access to personal protective equipment and safe transportation, as well as fundamental changes to interactions with clients. Agencies also faced challenges acquiring personal protective equipment for their aides. This research points to needed resources to support home care aides and home health agencies both during a public health crisis and in the future.


Asunto(s)
COVID-19/epidemiología , Auxiliares de Salud a Domicilio/psicología , Auxiliares de Salud a Domicilio/normas , Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Salud Laboral/normas , Pandemias , Equipo de Protección Personal/normas , Equipo de Protección Personal/provisión & distribución , Investigación Cualitativa , SARS-CoV-2 , Transportes/normas , Adulto Joven
5.
J Transl Med ; 18(1): 451, 2020 11 30.
Artículo en Inglés | MEDLINE | ID: covidwho-949113

RESUMEN

BACKGROUND: During the coronavirus disease-2019 (COVID-19) pandemic, Italian hospitals faced the most daunting challenges of their recent history, and only essential therapeutic interventions were feasible. From March to April 2020, the Laboratory of Advanced Cellular Therapies (Vicenza, Italy) received requests to treat a patient with severe COVID-19 and a patient with acute graft-versus-host disease with umbilical cord-derived mesenchymal stromal cells (UC-MSCs). Access to clinics was restricted due to the risk of contagion. Transport of UC-MSCs in liquid nitrogen was unmanageable, leaving shipment in dry ice as the only option. METHODS: We assessed effects of the transition from liquid nitrogen to dry ice on cell viability; apoptosis; phenotype; proliferation; immunomodulation; and clonogenesis; and validated dry ice-based transport of UC-MSCs to clinics. RESULTS: Our results showed no differences in cell functionality related to the two storage conditions, and demonstrated the preservation of immunomodulatory and clonogenic potentials in dry ice. UC-MSCs were successfully delivered to points-of-care, enabling favourable clinical outcomes. CONCLUSIONS: This experience underscores the flexibility of a public cell factory in its adaptation of the logistics of an advanced therapy medicinal product during a public health crisis. Alternative supply chains should be evaluated for other cell products to guarantee delivery during catastrophes.


Asunto(s)
COVID-19/terapia , Atención a la Salud/organización & administración , Hielo Seco , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas/citología , Sistemas de Atención de Punto/organización & administración , Transportes , Enfermedad Aguda , COVID-19/epidemiología , COVID-19/patología , Proliferación Celular , Supervivencia Celular , Células Cultivadas , Trasplante de Células Madre de Sangre del Cordón Umbilical/efectos adversos , Atención a la Salud/normas , Equipos y Suministros de Hospitales/normas , Equipos y Suministros de Hospitales/provisión & distribución , Enfermedad Injerto contra Huésped/etiología , Enfermedad Injerto contra Huésped/patología , Enfermedad Injerto contra Huésped/terapia , Humanos , Italia/epidemiología , Administración de Materiales de Hospital/organización & administración , Administración de Materiales de Hospital/normas , Trasplante de Células Madre Mesenquimatosas/métodos , Trasplante de Células Madre Mesenquimatosas/normas , Células Madre Mesenquimatosas/fisiología , Organización y Administración/normas , Pandemias , Fenotipo , Sistemas de Atención de Punto/normas , SARS-CoV-2/fisiología , Índice de Severidad de la Enfermedad , Transportes/métodos , Transportes/normas
6.
Int J Environ Res Public Health ; 17(16)2020 08 12.
Artículo en Inglés | MEDLINE | ID: covidwho-717728

RESUMEN

In response to the emergent public health event of COVID-19, the efficiency of transport of medical waste from hospitals to disposal stations is a worthwhile issue to study. In this paper, based on the actual situation of COVID-19 and environmental impact assessment guidelines, an immune algorithm is used to establish a location model of urban medical waste storage sites. In view of the selection of temporary storage stations and realistic transportation demand, an efficiency-of-transport model of medical waste between hospitals and temporary storage stations is established by using an ant colony-tabu hybrid algorithm. In order to specify such status, Wuhan city in Hubei Province, China-considered the first city to suffer from COVID-19-was chosen as an example of verification; the two-level model and the immune algorithm-ant colony optimization-tabu search (IA-ACO-TS) algorithm were used for simulation and testing, which achieved good verification. To a certain extent, the model and the algorithm are proposed to solve the problem of medical waste disposal, based on transit temporary storage stations, which we are convinced will have far-reaching significance for China and other countries to dispatch medical waste in response to such public health emergencies.


Asunto(s)
Algoritmos , Infecciones por Coronavirus/epidemiología , Eliminación de Residuos Sanitarios/métodos , Neumonía Viral/epidemiología , Transportes/métodos , Población Urbana , Betacoronavirus , COVID-19 , China/epidemiología , Ciudades , Humanos , Pandemias , Salud Pública , SARS-CoV-2 , Transportes/normas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA